Genmab Announces Positive Regulatory Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
COPENHAGEN, Denmark--(BUSINESS WIRE)--Nov 27, 2023--
Source: valdostadailytimes.com
Page 5 - Data From News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Data From. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Data From Today - Breaking & Trending Today
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced updates from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for...
Source: prnewswire.com
No Evidence Linking COVID-19 Vaccines to Infant Mortality Increase
Rising infant mortality in the US sparks speculation about COVID-19 vaccination, but there's no evidence to support this claim.
Source: washingtoninformer.com
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA23
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
Source: prnewswire.com
Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the
Eighteen total abstracts accepted for presentation and publication, including results from four clinical trials evaluating epcoritamab in multiple treatment settings and patient populationsOral presentations highlighting new findings from a clinical trial of epcoritamab in patients with relapsed/refractory (R/R) dif...
Source: pharmiweb.com